| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/26/1991 | CA1280690C Method for screening and treatment |
| 02/24/1991 | WO1991002517A1 Process for preparation of an oil in water emulsion of a drug |
| 02/23/1991 | CA2022443A1 Pulmonary surfactant protein fragments |
| 02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/21/1991 | WO1991002078A1 Tumour necrosis factor binding ligands |
| 02/21/1991 | WO1991001765A1 A phospholipid delivery system |
| 02/21/1991 | WO1991001760A1 Human tumor cells implanted in non-human animals |
| 02/21/1991 | WO1991001757A1 Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent |
| 02/21/1991 | WO1991001743A1 Stabilized protein or peptide conjugates |
| 02/21/1991 | WO1990011782A3 Immunoconjugates and prodrugs and their use in association for drug delivery |
| 02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/20/1991 | EP0413583A2 Clear, stable cromolyn formulation |
| 02/20/1991 | EP0413538A1 Long active injectable formulations containing triacetin |
| 02/20/1991 | EP0413533A1 Microencapsulated taste-masked water-insoluble NSAID drug materials |
| 02/20/1991 | EP0413528A1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 02/20/1991 | EP0413299A1 Antibiotic composition |
| 02/20/1991 | EP0413281A2 Drug carrier |
| 02/20/1991 | EP0413246A2 Reparation of parenteral forms, their application in a kit and 5-Fluorcytosin-Monochlorhydrate |
| 02/20/1991 | EP0413188A2 Method for producung an unmodified intravenous IgM- and/or IgA-containing immunoglobulin preparation |
| 02/20/1991 | EP0413171A1 Strong analgesic composition and process for its preparation |
| 02/20/1991 | EP0413061A1 Controlled-release oral dosage forms comprising different cellulose ethers |
| 02/20/1991 | EP0413056A1 Method for reducing astringency and bitterness of tannic acid |
| 02/20/1991 | CN1011659B Preparation of a composition based on a finely divided active principle of low water solubility |
| 02/19/1991 | WO1991002704A1 Ferritin analogs |
| 02/19/1991 | WO1991002545A1 Pharmaceutical compositions |
| 02/19/1991 | WO1991002538A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
| 02/19/1991 | WO1991002528A1 Ketotifen preparation for external use |
| 02/19/1991 | US4994560 Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
| 02/19/1991 | US4994558 Immunoglobulin conjugates |
| 02/19/1991 | US4994490 Novel N-(sulfomethyl)-N'-arylureas |
| 02/19/1991 | US4994445 Aqueous solutions with metal salts; cardiovascular disorders |
| 02/19/1991 | US4994374 Diagnostic method of cirrhosis and hepatic cancer |
| 02/19/1991 | US4994279 Multi-layer granule |
| 02/19/1991 | US4994276 Directly compressible sustained release excipient |
| 02/19/1991 | US4994260 Pharmaceutical mixture |
| 02/19/1991 | US4994023 Electrochemical drug release and article |
| 02/19/1991 | CA2065044A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
| 02/19/1991 | CA2064588A1 Ketotifen preparation for external use |
| 02/19/1991 | CA2064069A1 Ferritin analogs |
| 02/19/1991 | CA2021441A1 Process for the manufacture of parenteral application formulations |
| 02/19/1991 | CA1280411C Azo-containing polymers and method of use thereof |
| 02/19/1991 | CA1280367C Pharmaceutical composition of the type which undergoes liquid-gel phase transition |
| 02/18/1991 | WO1991002553A2 Transdermal nitroglycerin patch with penetration enhancers |
| 02/18/1991 | CA2064845A1 Transdermal nitroglycerin patch with penetration enhancers |
| 02/18/1991 | CA2023349A1 Agents for the treatment of conditions of heavy pain and processes for preparing said agents |
| 02/17/1991 | CA2022772A1 Antibiotic composition |
| 02/15/1991 | CA2022892A1 Long active injectable formulations containing triacetin |
| 02/14/1991 | DE3926751A1 Storage stable soln. of alkaloid, esp. atropine - contg. water absorbent beads, esp. mol. sieve, partic. for use in aerosols to deliver very precise doses |
| 02/13/1991 | EP0412877A1 Oral galenic form to improve bioavailability |
| 02/13/1991 | EP0412771A1 Polysiloxane-grafted copolymer topical binder composition with novel fluorochemical comonomer and method of coating therewith |
| 02/13/1991 | EP0412643A1 Flow control system for ink cartridges |
| 02/13/1991 | EP0412554A2 Sustained-release preparation for administration into brain |
| 02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
| 02/13/1991 | CN1049101A Improved intravaginal treatment of vaginal infections with buffered metranidazole compositions |
| 02/13/1991 | CN1049099A Compound xidi iodine sucked tablet and its making method |
| 02/13/1991 | CN1011572B Process of the preparation of basic formulations of quinolonecarboxylic acids |
| 02/12/1991 | US4992478 Antiinflammatory skin moisturizing composition and method of preparing same |
| 02/12/1991 | US4992445 Transdermal delivery of pharmaceuticals |
| 02/12/1991 | US4992422 Compositions comprising 1-substituted azacycloalkanes |
| 02/12/1991 | US4992419 Freeze drying with buffer, urea, amino acids; storage stability, compatible |
| 02/12/1991 | US4992280 Homogeneous dispersion of liquid flavorant and polyvinyl acetate |
| 02/12/1991 | US4992276 Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and thymol and methods for preparing same |
| 02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
| 02/12/1991 | US4992259 Stable oral composition of zinc |
| 02/12/1991 | CA1280111C Composition for transdermal drug delivery |
| 02/10/1991 | CA2022851A1 Oily composition for external application |
| 02/08/1991 | WO1991001758A1 Biologically active drug polymer derivatives |
| 02/08/1991 | CA2022447A1 Oral dosage form improving the biovailability |
| 02/07/1991 | WO1991001144A1 Labeled polypeptide derivatives |
| 02/07/1991 | WO1990015141A3 Self-assembled, defective, non-self-propagating viral particles |
| 02/06/1991 | EP0411629A2 A process for micronizing slightly-soluble drug |
| 02/06/1991 | EP0411619A1 Formulations of phenytoin sodium for intravenous administration |
| 02/06/1991 | EP0153926B1 Microdroplets of water-insoluble drugs |
| 02/06/1991 | CA2022632A1 Pharmaceutical formulation |
| 02/05/1991 | US4990530 Indomethacin injections and their production method |
| 02/05/1991 | US4990501 Film forming composition for topical use |
| 02/05/1991 | US4990341 Analgesics; time-release agents |
| 02/05/1991 | US4990337 Increased solubility and dispersibility |
| 02/05/1991 | CA2022670A1 Human tumor cells implanted in non-human animals |
| 02/04/1991 | WO1991001718A1 Method of photostabilizing eyewash and photostabilized eyewash |
| 02/04/1991 | WO1991001716A1 Skin cream preparation for external use |
| 02/03/1991 | WO1991002000A1 Il-2 deletion mutants |
| 02/03/1991 | CA2064696A1 Il-2 deletion mutants |
| 02/03/1991 | CA2022513A1 Formulations of phenytoin sodium for intravenous administration |
| 02/02/1991 | CA2022091A1 N-acylurea and o-acylisourea derivatives of hyaluronic acid |
| 02/01/1991 | WO1991001761A1 Shelf stable aspirin solutions |
| 02/01/1991 | WO1991001717A1 A podophyllotoxin preparation containing triglycerides |
| 02/01/1991 | CA2064035A1 Shelf stable aspirin solutions |
| 01/31/1991 | DE4020511A1 Medicaments for treating e.g. hypercalcaemia - contg. 24,25-di:hydroxy-cholecalciferol together with sesame oil for improved stability |
| 01/30/1991 | EP0410958A1 Process to prepare stable injectable compositions |
| 01/30/1991 | EP0410422A2 A highly absorbable pharmaceutical composition |
| 01/30/1991 | EP0410348A1 Topical spironolactone composition |
| 01/30/1991 | EP0410236A2 Process for the production of carotinoid preparations |
| 01/30/1991 | EP0410099A1 Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
| 01/30/1991 | EP0409940A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids. |
| 01/30/1991 | EP0409862A1 Topical preparations. |
| 01/30/1991 | EP0321548A4 Novel amphiphilic nucleic acid conjugates |
| 01/29/1991 | US4988787 Alternating copolymers, a process for their preparation, and a method of use thereof |
| 01/29/1991 | US4988722 Parenteral compositions |
| 01/29/1991 | US4988696 Dermal treatment of worm diseases in cats with praziquantel |